Phase 2 Randomized Trial of Neoadjuvant or Palliative Chemotherapy with or without Immunotherapy for Peritoneal Mesothelioma (Alliance: A092001)
- Citation:
- J Clin Oncol vol 40 (16_suppl) TPS8598
- Meeting Instance:
- ASCO 2022
- Year:
- 2022
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- No-Endpoint
- Analysis:
- Trial-Description-Only
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Parents:
- None
- Children:
- None
- Program:
- OGC
- Primary Committee:
- Experimental
- Sec. Committees:
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, U24CA196171
- Corr. Author:
- Authors:
- Aaron Mansfield Austin Goodrich Nathan Foster Vinicius Ernani Liza Villaruz Patrick Forde Kanwal Raghav Paul Romesser Krista Garbacz Liang Cao Mary Salvatore Anja Roden Steven Powell Ardaman Shergill Pamela Munster Gary Schwartz Travis Grotz
- Networks:
- CA136, COLUMBIA, LAPS-IL057, LAPS-MD017, LAPS-MN026, LAPS-NY016, LAPS-PA015, LAPS-TX035, SANFORD, TN008
- Study
- Alliance-A092001
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: